AarogyaAI
AarogyaAI® is a healthtech startup revolutionizing healthcare with Artificial Intelligence and genomics for precision diagnosis of antimicrobial resistance (AMR). Their product, AAICare®, leverages AI and machine learning to rapidly diagnose drug resistance, enabling clinicians to make data-driven treatment decisions. The platform is pathogen and sequencing hardware agnostic, accessible across devices, and trained on global databases and literature to detect novel mutations contributing to drug resistance. Founded in 2019, AarogyaAI® has received seed funding and strategic investment, and has been featured in various tech and health publications for its innovative approach to combating AMR and improving diagnostic speed and accuracy for diseases like Drug-Resistant Tuberculosis.
AarogyaAI
AarogyaAI® is a healthtech startup revolutionizing healthcare with Artificial Intelligence and genomics for precision diagnosis of antimicrobial resistance (AMR). Their product, AAICare®, leverages AI and machine learning to rapidly diagnose drug resistance, enabling clinicians to make data-driven treatment decisions. The platform is pathogen and sequencing hardware agnostic, accessible across devices, and trained on global databases and literature to detect novel mutations contributing to drug resistance. Founded in 2019, AarogyaAI® has received seed funding and strategic investment, and has been featured in various tech and health publications for its innovative approach to combating AMR and improving diagnostic speed and accuracy for diseases like Drug-Resistant Tuberculosis.